Long-Term Survival Differences Among Low-Anxious, High-Anxious and Repressive Copers Enrolled in the Montreal Heart Attack Readjustment Trial
Nancy Frasure-Smith, PhD,
François Lespérance, MD,
Ginette Gravel, MSc,
Aline Masson, MSc,
Martin Juneau, MD and
Martial G. Bourassa, MD
From the Department of Psychiatry (N.F.-S., F.L.) and School of Nursing (N.F.-S.), McGill University; the Research Center, Montreal Heart Institute (N.F.-S., F.L., G.G., A.M., M. J., M.G.B.); the Departments of Psychiatry (N.F.-S., F.L.) and Medicine (M. J., M.G.B.), University of Montreal; and the Research Center, Centre Hospitalier de lUniversité de Montréal (N.F.-S., F.L.), Montreal, Canada.

View larger version (27K):
[in a new window]
|
Fig. 1. Cumulative covariate-adjusted survival over 1825 days postdischarge in men and women in the treatment and control groups of the M-HART Program. 95% CI = 95% confidence interval.
|
|

View larger version (22K):
[in a new window]
|
Fig. 2. Cumulative covariate-adjusted survival over 1825 days postdischarge in repressors in the treatment and control groups of the M-HART Program.
|
|

View larger version (25K):
[in a new window]
|
Fig. 3. Cumulative covariate-adjusted survival over 1825 days postdischarge in highly anxious men in the treatment and control groups of the M-HART Program.
|
|
Copyright © 2002 by the American Psychosomatic Society